Determining the Minimal Effective Dose of Static Stretching for Increasing Range of Motion in Adults (NCT06960590) | Clinical Trial Compass
CompletedNot Applicable
Determining the Minimal Effective Dose of Static Stretching for Increasing Range of Motion in Adults
Poland51 participantsStarted 2025-03-25
Plain-language summary
The study is planned to be conducted in 2025. The methods used in the study are non-invasive methods. The study groups will perform 1 to 3 static stretching sessions per week. The number of series per session will be from 1 to 3. The static stretching time of the back band in the series will be from 20 s to 60 s. The total stretching time per week will be from 45 s to 135 s. The break between series will be 45 s, and the duration of the intervention will be from 6 to 8 weeks. During stretching, the subject maintains a maximum bend with straight knee joints for a specified time. Before starting the study, participants will undergo a toe-to-floor test to assess the flexibility of the back band. The test will be repeated after the intervention. The aim of the study is to determine the minimum effective dose of static stretching. Currently, anecdotal evidence suggests that this dose is 90 seconds of static stretching per week.
The study does not involve any likelihood of harm to study participants as a result of participating in the study.
Who can participate
Age range
18 Years – 25 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age over 18 years,
* No lower limb injuries, no spinal injuries and no craniocerebral injuries in the last 6 months,
* No lower limb surgeries, no spinal surgeries and no central nervous system surgeries in the last 6 months,
Exclusion Criteria:
* Age under 18 years
* Injuries to the lower limbs, spine or craniocerebral injuries within the last 6 months,
* Surgical procedures to the lower limbs, spine or surgical procedures to the central nervous system within the last 6 months,
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Flexibility
Timeframe: From registration to completion of the study, the duration is up to 8 weeks
Trial details
NCT IDNCT06960590
SponsorJózef Piłsudski University of Physical Education